研究动态
Articles below are published ahead of final publication in an issue. Please cite articles in the following format: authors, (year), title, journal, DOI.

让欧洲社会参与癌症研究和治疗的前沿。

Engaging European society at the forefront of cancer research and care.

发表日期:2023 Mar 20
作者: Michael Baumann, Julio Celis, Ulrik Ringborg, Manuel Heitor, Anton Berns, Tit Albreht, Jeliazko Arabadjiev, Michael Boutros, Mario Brandenburg, Helena Canhao, Fatima Carneiro, Christine Chomienne, Francesco De Lorenzo, Alexander M M Eggermont, Angel Font, Elena Garralda, Margarida Goulart, Rui Henrique, Mark Lawler, Lena Maier-Hein, Francoise Meunier, Simon Oberst, Pedro Oliveira, Maria Papatriantafyllou, Joachim Schüz, Eric Solary, Alfonso Valencia, Rosalia Vargas, Elisabete Weiderpass, Nils Wilking
来源: Epigenetics & Chromatin

摘要:

欧洲癌症研究利益相关者于2022年10月在德国海德堡举行第5届Gago欧洲癌症政策会议,讨论欧洲当前的癌症研究和癌症护理政策情况。与会者强调了现有欧洲癌症研究计划中存在的差距,包括欧洲癌症计划(ECBP)、癌症使命(MoC)、了解癌症(UNCAN.eu)和联合行动CRANE,并提出了下一个优先事项,形成了海德堡癌症研究宣言。本次会议报告呈现了所有讨论内容,重点关注了如何有效塑造翻译、预防、临床和结果癌症研究的基础设施,注重实施和可持续性,并同时参与患者和公众。此外,我们总结了有关如何引入欧洲癌症研究数字化框架的建议。最后,我们讨论了建立欧洲协作癌症研究环境所需的结构、承诺和资源,以实现创新所需的规模。本文受版权保护。保留所有权利。
European cancer research stakeholders met in October 2022 in Heidelberg, Germany, at the 5th Gago conference on European Cancer Policy, to discuss the current cancer research and cancer care policy landscape in Europe. Meeting participants highlighted gaps in the existing European programmes focusing on cancer research, including Europe's Beating Cancer Plan (ECBP), the Mission on Cancer (MoC), Understanding Cancer (UNCAN.eu), and the joint action CRANE, and put forward the next priorities, in the form of the Heidelberg Manifesto for cancer research. This meeting report presents all discussions that shed light onto how infrastructures can be effectively shaped for translational, prevention, clinical and outcomes cancer research, with a focus on implementation and sustainability and while engaging patients and the public. In addition, we summarize recommendations on how to introduce frameworks for the digitalization of European cancer research. Finally, we discuss what structures, commitment and resources are needed to establish a collaborative cancer research environment in Europe to achieve the scale required for innovation.This article is protected by copyright. All rights reserved.